|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.341
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.288
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.204
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.154
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.144
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.138
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.135
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.127
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.127
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.122
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.115
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.109
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.107
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.104
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.102
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.099
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.098
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.096
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.091
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.091
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.090
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.089
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.087
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.086
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.082
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.081
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.079
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.077
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.076
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.075
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.074
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.073
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.073
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.072
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.072
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.071
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.070
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.070
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.069
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.069
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.068
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.068
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.063
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.062
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.060
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.060
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.059
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.059
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.058
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.057
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.057
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.056
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.055
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.055
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.054
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.053
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.053
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.051
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.051
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.051
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.050
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.050
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.049
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.049
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.049
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.048
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.048
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.048
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.048
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.048
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.048
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.047
|
|
|
|
metaphase plate congression
|
GO:0051310 |
2 |
0.047
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.047
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.046
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.046
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.046
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.046
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.045
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.045
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.045
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.045
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.044
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.044
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.043
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.043
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.043
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.043
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.042
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.042
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.042
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.041
|
|
|
|
spindle assembly
|
GO:0051225 |
13 |
0.041
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.041
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.041
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.041
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.040
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.040
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.040
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.040
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.039
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.039
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.039
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.038
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.038
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.038
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.038
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.037
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.037
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.037
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.037
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.037
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.036
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.036
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.036
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.036
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.036
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.035
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.035
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.035
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.035
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.034
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.033
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.033
|
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.033
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.033
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.033
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.033
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.032
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.032
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.032
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.032
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.031
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.031
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.031
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.031
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.031
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.030
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.030
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.030
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.030
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.029
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.029
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.029
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.029
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.029
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.029
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.028
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.028
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.028
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.028
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.028
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.027
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.027
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.027
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.027
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.027
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.027
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.027
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.027
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.027
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.027
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.027
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.026
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.026
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.026
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.026
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.026
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.025
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.025
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.025
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.025
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.025
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.025
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.025
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.025
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.025
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.025
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.025
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.025
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.025
|
|
|
|
myeloid dendritic cell activation
|
GO:0001773 |
25 |
0.025
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.024
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.024
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.024
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.024
|
|
|
|
spermatogenesis exchange of chromosomal proteins
|
GO:0035093 |
4 |
0.024
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.024
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.024
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.024
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.023
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.023
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.023
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.023
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.022
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.022
|
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.022
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.022
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.022
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.022
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.022
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.022
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.021
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.021
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.021
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.021
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.021
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.021
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.021
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.021
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.021
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.021
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.021
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.021
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.021
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.020
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.020
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.020
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.020
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.020
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.020
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.020
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.020
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.020
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.020
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.020
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.020
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.020
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.019
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.019
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.019
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.019
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.019
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.019
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.019
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.019
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.018
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.018
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.018
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.018
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.018
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.018
|
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.018
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.018
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.018
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.018
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.018
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.018
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.017
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.017
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.017
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.017
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.017
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
|
spindle assembly involved in mitosis
|
GO:0090307 |
4 |
0.017
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.017
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.017
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
|
epithelial structure maintenance
|
GO:0010669 |
9 |
0.017
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.017
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.016
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.016
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.016
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.016
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.016
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.016
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.016
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.016
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.016
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
|
face development
|
GO:0060324 |
38 |
0.016
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.016
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.016
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.016
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.016
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.016
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.016
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.015
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.015
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.015
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.015
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.015
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.015
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.015
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.015
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.015
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.015
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.015
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.015
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.015
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.015
|
|
|
|
maintenance of location in cell
|
GO:0051651 |
24 |
0.015
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.015
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.015
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.015
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.015
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.015
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.014
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.014
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.014
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.014
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.014
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.014
|
|
|
|
cell cell signaling involved in metanephros development
|
GO:0072204 |
2 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.014
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.014
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.014
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.014
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.014
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.014
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.014
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.014
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.014
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.014
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.014
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.014
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.014
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.014
|
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
3 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.014
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.014
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.014
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.014
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.013
|
|
|
|
positive regulation of interleukin 18 production
|
GO:0032741 |
2 |
0.013
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.013
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.013
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.013
|
|
|
|
positive regulation of ubiquitin protein transferase activity
|
GO:0051443 |
4 |
0.013
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.013
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.013
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.013
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.013
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.013
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.013
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.013
|
|
|
|
detection of mechanical stimulus involved in sensory perception of pain
|
GO:0050966 |
4 |
0.013
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.013
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.013
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.013
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.013
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.013
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.013
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.013
|
|
|
|
positive regulation of mammary gland epithelial cell proliferation
|
GO:0033601 |
5 |
0.013
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.013
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.013
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.013
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.013
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.012
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.012
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.012
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.012
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.012
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.012
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.012
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.012
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.012
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.012
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.012
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.012
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.012
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.012
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.012
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.012
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.012
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.012
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.012
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.012
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.012
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.012
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.012
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.012
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.012
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.012
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.012
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.012
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.011
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.011
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
19 |
0.011
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.011
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.011
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.011
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.011
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.011
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.011
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.011
|
|
|
|
acetate ester metabolic process
|
GO:1900619 |
3 |
0.011
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.011
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.011
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.011
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.011
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.011
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.011
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.011
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.011
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.011
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.011
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.011
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.011
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.011
|
|
|
|
lipopolysaccharide metabolic process
|
GO:0008653 |
2 |
0.011
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.011
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.011
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.011
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.011
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.011
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.011
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.011
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.011
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.011
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.011
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.011
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.011
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.011
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.011
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.011
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.011
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.011
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.011
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.011
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.010
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.010
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.010
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.010
|
|
